SOURCE: Clinical and Laboratory Standards Institute

Clinical and Laboratory Standards Institute

August 30, 2010 14:43 ET

CLSI and APHL Announce New Teleconference on Point-of-Care Glucose Devices

WAYNE, PA--(Marketwire - August 30, 2010) -  The Clinical and Laboratory Standards Institute (CLSI) and Association of Public Health Laboratories (APHL) are offering a teleconference to the health care community to learn more about the different considerations surrounding acceptance criteria on point-of-care (POC) glucose devices. The teleconference on September 30 is titled "POC Glucose Devices: Perspectives From the Hospital, Government, and Vendor."

The US Food and Drug Administration (FDA) recently held a public forum on glucose meter devices to gather wide perspectives on the clinical requirements for blood glucose meter accuracy and precision. Using the CLSI consensus process in gathering balanced viewpoints from industry, professional societies, and government bodies, this educational program will provide an overview of different perspectives surrounding the glucose device acceptance criteria for both self-testing and professional use, and possibly expand the presentations at the most recent FDA public meeting.

"This teleconference will not only highlight the need for glucose meter accuracy and precision, but also discuss the studies that have been performed and what is to come from the many organizations and associations looking into guidelines around this issue," said Marcy Anderson, MS, MT(ASCP), Director of Development and Education, CLSI.

The teleconference will help participants to describe differences in the use of glucose meters in self-testing vs hospital or professional settings. They will also understand the differences between the perspectives of the government agency, professional expert, and POC glucose vendor representative. There will be an opportunity to ask questions at the end of the program.

Speakers include:

  • Alan Cariski, MD, JD
    VP, Worldwide Medical Affairs, LifeScan Inc., Milpitas, California

  • Courtney Harper, PhD
    Director, FDA Division of Chemistry and Toxicology Devices, Silver Spring, Maryland

  • Mitch Scott, PhD
    Director, Division of Laboratory Medicine at Washington University Hospital, St. Louis, Missouri

Upcoming point-of-care teleconferences:

Register for the upcoming teleconferences at www.aphl.org/clsi. Discounts are offered for conference series registration.

APHL is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) P.A.C.E.® Program. Participants will be awarded contact hours for each program they successfully complete. P.A.C.E.® is accepted by all licensure states except Florida. Florida continuing education credit will also be offered.

CLSI is a volunteer-driven, membership-supported, nonprofit organization dedicated to developing standards and guidelines for the health care and medical testing community through a consensus process that balances the perspectives of industry, government, and the health care professions. For additional information on CLSI, visit the CLSI website at www.clsi.org or call 610.688.0100.

Contact Information

  • Contact:
    Amanda Holm
    Senior Marketing Manager
    Phone: 610.688.0100 ext. 129
    E-mail: Email Contact